Michael Shawn Moran
Insider Reports History
- Location
- Woodcliff, NJ
- Signature
- /s/ Brian Cahill, Attorney-in-Fact
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Michael Shawn Moran:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| EAGLE PHARMACEUTICALS, INC. | EVP, Chief Commercial Officer | Common Stock | 32,115 | $164,750 | $5.13 | 28 Feb 2022 | Direct |
Insider Reports Filed by Michael Shawn Moran
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| EGRX | EAGLE PHARMACEUTICALS, INC. | 28 Feb 2022 | 1 | $0 | 4 | EVP, Chief Commercial Officer | 02 Mar 2022, 17:11 |
| EGRX | EAGLE PHARMACEUTICALS, INC. | 02 Feb 2022 | 1 | -$33,412 | 4 | EVP, Chief Commercial Officer | 04 Feb 2022, 15:57 |
| EGRX | EAGLE PHARMACEUTICALS, INC. | 31 Jan 2022 | 1 | -$9,647 | 4 | EVP, Chief Commercial Officer | 01 Feb 2022, 17:46 |
| EGRX | EAGLE PHARMACEUTICALS, INC. | 07 Jan 2022 | 1 | -$4,557 | 4 | EVP, Chief Commercial Officer | 11 Jan 2022, 15:42 |
| EGRX | EAGLE PHARMACEUTICALS, INC. | 05 Jan 2022 | 1 | -$76,593 | 4 | EVP, Chief Commercial Officer | 07 Jan 2022, 15:39 |
| EGRX | EAGLE PHARMACEUTICALS, INC. | 27 Sep 2021 | 0 | $0 | 3 | EVP, Chief Commercial Officer | 07 Oct 2021, 19:03 |